More than 8 million Asians to be blinded by glaucoma in 2 years

Article

A survey, released by the global campaign, All Eyes on Glaucoma, has revealed that more than 8.4 million people in Asia will be blinded by glaucoma by 2010 if they do not undergo treatment.

A survey, released by the global campaign, All Eyes on Glaucoma, has revealed that more than 8.4 million people in Asia will be blinded by glaucoma by 2010 if they do not undergo treatment.

The survey, which interviewed 935 people across nine countries, including China and India, found that awareness levels were low amongst the population, with only 54% having heard of glaucoma.

Clement Tham, professor of ophthalmology at the Chinese University of Hong Kong admitted that Asians were more prone to glaucoma because their eyes are generally smaller than those of Westerners, which leads to higher pressure within the eye. Prin Rojanapongpun, an ophthalmology professor in Thailand, also blamed excessive use of over-the-counter steroid eye drops, which could lead to glaucoma, for the increase.

According to the survey, 9.4 million people aged 40 or over in China alone suffer from the disease and this figure is expected to increase by 6 million by 2020.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.